Found 27 matching trials
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation PHASE3 Tegaserod is an aminoguanidine indole compound and a member of a new class ...
Show More Learn More & Join Trial
Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation PHASE4 Tegaserod (HTF919) is an aminoguanidine indole compound and a member of a n...
Show More Learn More & Join Trial
The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia PHASE4 To demonstrate the effects of tegaserod on gastrointestinal scintigraphic o...
Show More Location
Multiple Locations
Learn More & Join Trial
Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS) PHASE4 Visceral and somatic hypersensitivity as evidence of central sensory sensit...
Show More Learn More & Join Trial
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation NA Idiopathic or functional constipation is a common disorder, affecting up to...
Show More Location
Queen Mary Hospital
Learn More & Join Trial
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis PHASE4 This study will assess gastric emptying in patients with symptoms of diabet...
Show More Location
The University of Kansas Medical Center
Learn More & Join Trial
The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia. PHASE3 Investigate the role of tegaserod in modulating gastric sensitivity to mech...
Show More Location
Oklahoma Foundation for Digestive Research
Learn More & Join Trial
Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation. PHASE3 Tegaserod (HTF919) is an aminoguanidine indole compound and a member of a c...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy PHASE2 This study is being done to evaluate the safety, tolerability and satisfact...
Show More Learn More & Join Trial
A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation N/A To provide tegaserod to eligible women adult patients who did not have sati...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial